The Parkinson’s Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network

[1]  H. Bellen,et al.  Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels, Similar to α-Synuclein Gain. , 2018, Cell metabolism.

[2]  J. Bonifacino,et al.  A Neurodevelopmental Disorder Caused by Mutations in the VPS51 Subunit of the GARP and EARP Complexes , 2018, bioRxiv.

[3]  Sonja W. Scholz,et al.  Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable risk , 2018, bioRxiv.

[4]  Sonja W. Scholz,et al.  Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk , 2018 .

[5]  M. Cookson,et al.  Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice , 2018, Human molecular genetics.

[6]  James E. Tomkins,et al.  Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins , 2018, Proteomics.

[7]  M. Cookson,et al.  LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network , 2018, Human molecular genetics.

[8]  D. Mash,et al.  Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers , 2017, Brain : a journal of neurology.

[9]  S. Pfeffer,et al.  Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase , 2017, The EMBO journal.

[10]  M. Nalls,et al.  A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci , 2017, Nature Genetics.

[11]  F. Oppermann,et al.  Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells , 2017, Scientific Reports.

[12]  Simon C. Potter,et al.  Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease , 2017, Brain : a journal of neurology.

[13]  P. Verstreken,et al.  A LRRK2-Dependent EndophilinA Phosphoswitch Is Critical for Macroautophagy at Presynaptic Terminals , 2016, Neuron.

[14]  A. Reith,et al.  Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors , 2016, The Biochemical journal.

[15]  V. D’Agati,et al.  LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts , 2016, Scientific Reports.

[16]  Andrew B West,et al.  G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons , 2016, The Journal of Neuroscience.

[17]  Matthias Mann,et al.  Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases , 2016, eLife.

[18]  Y. Maeda,et al.  Post-Golgi anterograde transport requires GARP-dependent endosome-to-TGN retrograde transport , 2015, Molecular biology of the cell.

[19]  Elie Needle,et al.  Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration* , 2015, The Journal of Biological Chemistry.

[20]  W. Seol,et al.  An early endosome regulator, Rab5b, is an LRRK2 kinase substrate. , 2015, Journal of biochemistry.

[21]  Claudia Manzoni,et al.  Computational analysis of the LRRK2 interactome , 2015, PeerJ.

[22]  A. West.  Ten Years and Counting: Moving Leucine-Rich Repeat Kinase 2 Inhibitors to the Clinic , 2014, Movement disorders : official journal of the Movement Disorder Society.

[23]  M. Nalls,et al.  Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7 , 2014, Nature Communications.

[24]  M. Guo,et al.  Novel ethyl methanesulfonate (EMS)-induced null alleles of the Drosophila homolog of LRRK2 reveal a crucial role in endolysosomal functions and autophagy in vivo , 2014, Disease Models & Mechanisms.

[25]  P. Cullen,et al.  Retromer Binding to FAM21 and the WASH Complex Is Perturbed by the Parkinson Disease-Linked VPS35(D620N) Mutation , 2014, Current Biology.

[26]  W. Hong,et al.  A Role of Rab29 in the Integrity of the Trans-Golgi Network and Retrograde Trafficking of Mannose-6-Phosphate Receptor , 2014, PloS one.

[27]  Todd A. Stone,et al.  Parkinson disease-associated mutation R1441H in LRRK2 prolongs the “active state” of its GTPase domain , 2014, Proceedings of the National Academy of Sciences.

[28]  Suneil K. Kalia,et al.  Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease , 2014, Proceedings of the National Academy of Sciences.

[29]  P. Giunti,et al.  Inhibition of LRRK2 kinase activity stimulates macroautophagy , 2013, Biochimica et biophysica acta.

[30]  K. Marder,et al.  RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk , 2013, Neuron.

[31]  Xiongwei Zhu,et al.  Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity. , 2013, Human molecular genetics.

[32]  M. Cookson,et al.  Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers , 2012, PloS one.

[33]  Xiaoxia Zhou,et al.  Retromer Guides STxB and CD8‐M6PR from Early to Recycling Endosomes, EHD1 Guides STxB from Recycling Endosome to Golgi , 2012, Traffic.

[34]  Shengdi Chen,et al.  Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning. , 2012, Human molecular genetics.

[35]  H. Cai,et al.  Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway , 2012, Molecular Neurodegeneration.

[36]  G. Churchill,et al.  Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP , 2011, Human molecular genetics.

[37]  M. Cookson,et al.  LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding , 2011, PloS one.

[38]  C. Schnell,et al.  LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice , 2011, Human molecular genetics.

[39]  Marc N. Offman,et al.  A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. , 2011, American journal of human genetics.

[40]  J. Bonifacino,et al.  Transport according to GARP: receiving retrograde cargo at the trans-Golgi network. , 2011, Trends in cell biology.

[41]  V. Baekelandt,et al.  Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant , 2011, Journal of neurochemistry.

[42]  Mark R. Cookson,et al.  The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease , 2010, Nature Reviews Neuroscience.

[43]  Javier G. Magadán,et al.  Ang2/Fat-Free Is a Conserved Subunit of the Golgi-associated Retrograde Protein Complex , 2010, Molecular biology of the cell.

[44]  Xiongwei Zhu,et al.  LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease , 2010, Neurobiology of Disease.

[45]  R. J. Kelleher,et al.  Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice , 2010, Proceedings of the National Academy of Sciences.

[46]  S. Pfeffer.  Multiple routes of protein transport from endosomes to the trans Golgi network , 2009, FEBS letters.

[47]  Yinhua Zhang,et al.  Regulation of endosomal clathrin and retromer‐mediated endosome to Golgi retrograde transport by the J‐domain protein RME‐8 , 2009, The EMBO journal.

[48]  Richard Wade-Martins,et al.  LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. , 2009, Human molecular genetics.

[49]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[50]  M. Nalls,et al.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. , 2009, The New England journal of medicine.

[51]  A. Pisani,et al.  R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice , 2009, Proceedings of the National Academy of Sciences.

[52]  J. Bonifacino,et al.  Dual Roles of the Mammalian GARP Complex in Tethering and SNARE Complex Assembly at the trans-Golgi Network , 2009, Molecular and Cellular Biology.

[53]  A. Paetau,et al.  Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo , 2009, Molecular Brain.

[54]  A. Singleton,et al.  Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease , 2008, The FEBS journal.

[55]  D. Standaert,et al.  Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity , 2008, Molecular Brain.

[56]  S. Yen,et al.  Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. , 2008, Biochemistry.

[57]  J. Trojanowski,et al.  Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration , 2008, The Journal of Neuroscience.

[58]  J. Bonifacino,et al.  Requirement of the human GARP complex for mannose 6-phosphate-receptor-dependent sorting of cathepsin D to lysosomes. , 2008, Molecular biology of the cell.

[59]  S. Pfeffer,et al.  A syntaxin 10–SNARE complex distinguishes two distinct transport routes from endosomes to the trans-Golgi in human cells , 2008, The Journal of cell biology.

[60]  Douglas L. Black,et al.  Neuronal regulation of alternative pre-mRNA splicing , 2007, Nature Reviews Neuroscience.

[61]  M. Cookson,et al.  The R1441C mutation of LRRK2 disrupts GTP hydrolysis. , 2007, Biochemical and biophysical research communications.

[62]  P. Emson,et al.  Localization of LRRK2 to membranous and vesicular structures in mammalian brain , 2006, Annals of neurology.

[63]  Min Jiang,et al.  High Ca2+-phosphate transfection efficiency in low-density neuronal cultures , 2006, Nature Protocols.

[64]  David W. Miller,et al.  Kinase activity is required for the toxic effects of mutant LRRK2/dardarin , 2006, Neurobiology of Disease.

[65]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.

[66]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[67]  Bor Luen Tang,et al.  Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform , 2002, The Journal of cell biology.

[68]  R. Scheller,et al.  Syntaxin 6 functions in trans-Golgi network vesicle trafficking. , 1997, Molecular biology of the cell.

[69]  J. M. Bravo-San Pedro,et al.  The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway , 2012, Cellular and Molecular Life Sciences.

[70]  Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia on behalf of the International Parkinson’s Disease Genomics Consortium (IPDGC) , 2022 .